Home  >  TopNews
  Bristol-Myers Squibb announces Opdivo in combo with Yervoy demonstrates clinical activity in previously treated patients with dMMR/mCRC,   January 22, 2018
  Laminate Medical begins patient enrollment in pivotal trial of VasQ device,   January 22, 2018
  Bluegrass Vascular begins patient enrollment in SAVE-US pivotal trial,   January 20, 2018
  Kite inks clinical collaboration with Pfizer to evaluate combination of Yescarta & utomilumab in large B-cell lymphoma,   January 20, 2018
  Daiichi Sankyo presents updated phase 1 data of DS-8201 in patients with HER2-expressing gastric cancer at ASCO 2018 symposium,   January 20, 2018
  Union govt’s timely regulations positioned Indian clinical trial industry on growth trajectory: Dr Chirag Trivedi,   January 20, 2018
  GC Pharma to initiate phase 2/3 trial of GC1102 for prevention of recurrence HBV infection,   January 19, 2018
  Amgen announces US FDA approves sNDA to add OS data from phase 3 trial to prescribing information for Kyprolis,   January 19, 2018
  Biohaven to begin clinical development of BHV-5000 to treat Rett syndrome,   January 19, 2018
  Bayer to present new data from Stivarga & Nexavar in advanced liver, colorectal & biliary tract cancers at ASCO GI 2018 cancer symposium,   January 18, 2018
  MyDx to initiate clinical trials on unique MyDx360 pain management formula,   January 18, 2018
  US FDA takes new steps to enhance transparency of trial information to support innovation, scientific inquiry related to new drugs,   January 18, 2018
  Castle Creek Pharma presents phase 2 study results of diacerein 1% ointment to treat EBS at Winter Clinical Dermatology Conference,   January 17, 2018
  Novartis CLARITY study shows Cosentyx more effective than Stelara in delivering clear skin in adults with plaque psoriasis at 12 weeks,   January 17, 2018
  SEMCO aswarded SBIR phase 1 NCI contract to study its lead molecules in preclinical model of triple negative breast cancer,   January 16, 2018
  Dynasil submits Xcede Technologies' application for first-in-human trial,   January 15, 2018
  Glenmark receives DCGI nod to start phase IIb dose range study of GRC 27864 to treat osteoarthritic pain,   January 15, 2018
  MERS antibodies produced in cattle safe, treatment well tolerated in phase 1 trial,   January 15, 2018
  US FDA accepts Resverlogix's phase 3 BETonMACE trial protocol amendments,   January 15, 2018
  Immunovia signs collaboration with Denmark’s Diabetes Center for Strategic Research for pancreas cancer study of new onset diabetics,   January 13, 2018

Copyright © 2016 Saffron Media Pvt. Ltd |